Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates

Second-generation COVID-19 vaccines could contribute to establish protective immunity against SARS-CoV-2 and its emerging variants. We developed COH04S1, a synthetic multiantigen modified vaccinia Ankara-based SARS-CoV-2 vaccine that co-expresses spike and nucleocapsid antigens. Here, we report COH0...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiuppesi, Flavia, Nguyen, Vu H., Park, Yoonsuh, Contreras, Heidi, Karpinski, Veronica, Faircloth, Katelyn, Nguyen, Jenny, Kha, Mindy, Johnson, Daisy, Martinez, Joy, Iniguez, Angelina, Zhou, Qiao, Kaltcheva, Teodora, Frankel, Paul, Kar, Swagata, Sharma, Ankur, Andersen, Hanne, Lewis, Mark G., Shostak, Yuriy, Wussow, Felix, Diamond, Don J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782996/
https://www.ncbi.nlm.nih.gov/pubmed/35064109
http://dx.doi.org/10.1038/s41541-022-00436-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782996/
https://www.ncbi.nlm.nih.gov/pubmed/35064109
http://dx.doi.org/10.1038/s41541-022-00436-6

Ejemplares similares